The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...
How Dementia Affects the Brain's Ability ... Machine Learning Reveals Behaviors Linked With Early Alzheimer's, Points to New Treatments Nov. 26, 2024 — Scientists used a new video-based machine ...
In a simulated trial, the Florey Dementia Index achieved mean absolute errors of 1.57 and 0.70 years for predicting mild cognitive impairment and Alzheimer's disease onset, respectively ...